The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genetic variants as predictive markers for ototoxicity and nephrotoxicity in patients (pts) with locally advanced head and neck cancer (LAHNC) treated with cisplatin-containing chemoradiotherapy (ccCRT).
 
Chantal Driessen
No Relationships to Disclose
 
Janneke Ham
No Relationships to Disclose
 
Dunja Maroeska W.M. Te Loo
No Relationships to Disclose
 
Esther Van Meerten
No Relationships to Disclose
 
Robert P. Takes
No Relationships to Disclose
 
Winette T.A. Van Der Graaf
Consulting or Advisory Role - Bayer; Bayer (I)
Speakers' Bureau - Bayer (I)
 
Johannes Kaanders
No Relationships to Disclose
 
Marieke J.H. Coenen
No Relationships to Disclose
 
Carla M.L.- Van Herpen
Consulting or Advisory Role - BMS Brazil (Inst); Ipsen (Inst); Merck (Inst); MSD (Inst)
Research Funding - AstraZeneca (Inst); Merck (Inst); MSD (Inst); Novartis (Inst)